OSCR vs TEM: Which Stock Is the Better Buy?
Oscar Health, Inc. and Tempus AI, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — OSCR vs TEM, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Oscar Health, Inc. (OSCR) | Tempus AI, Inc. (TEM) | |
|---|---|---|
| Market cap | $8.5B | $8.7B |
| Revenue (latest FY) | $11.70B | $1.27B |
| Net income (latest FY) | $-443.15M | $-245.03M |
| Revenue growth (5y CAGR) | 90.8% | 58.3% |
| Net margin | -3.8% | -19.3% |
| Return on equity | -45.3% | -49.9% |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 1 | 0 |
| Positive free cash flow | Yes | No |
Verify the comparison
Use the filing period and source shown by each tool before treating two figures as comparable.
See the full OSCR vs TEM breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open OSCR's full financials → Open TEM's full financials →More comparisons
Frequently asked questions
Which is bigger, OSCR or TEM?
Tempus AI, Inc. is larger by market capitalization — $8.7B versus $8.5B.
Which grows faster, OSCR or TEM?
Over the last five fiscal years, Oscar Health, Inc. grew revenue faster — 90.8%/yr versus 58.3%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.
Keep exploring
OSCR fundamentals → · TEM fundamentals → · All 1,500+ companies → · Free screener →